Royal Bank Of Canada Fusion Pharmaceuticals Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$7.9 - $21.32 $265,400 - $716,245	-33,595 Reduced 97.32%	924 $19,000
Q4 2023 Feb 14, 2024	BUY	$2.48 - $9.65 $75,181 - $292,539	30,315 Added 721.1%	34,519 $331,000
Q3 2023 Nov 14, 2023	BUY	$2.37 - $4.63 $5,605 - $10,949	2,365 Added 128.6%	4,204 $10,000
Q2 2023 Aug 14, 2023	SELL	$3.47 - $5.33 $1,263 - $1,940	-364 Reduced 16.52%	1,839 $8,000
Q1 2023 May 15, 2023	BUY	$3.03 - $5.13 $4,099 - $6,940	1,353 Added 159.18%	2,203 $8,000
Q4 2021 Feb 14, 2022	SELL	$4.17 - $7.78 $6,255 - $11,670	-1,500 Reduced 63.83%	850 $4,000
Q3 2021 Nov 15, 2021	BUY	$7.83 - $9.41 $9,396 - $11,292	1,200 Added 104.35%	2,350 $19,000
Q2 2021 Aug 16, 2021	BUY	$7.97 - $10.66 $9,165 - $12,259	1,150 New	1,150 $9,000

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.